RECENSA THERAPEUTICS

recensa-therapeutics-logo

Recensa is developing small molecules that activate the transcription factor Nrf2, a key modulator of antioxidant response. These molecules will be embedded in topical vehicles-such as creams or lotions-and will be tested in animal models of psoriasis so we can gain FDA approval for human clinical trials. Future products may target other diseases where oxidative stress is a key factor

#SimilarOrganizations #People #Financial #Website #More

RECENSA THERAPEUTICS

Industry:
Biotechnology Clinical Trials Therapeutics

Founded:
2016-01-01

Address:
Philadelphia, Pennsylvania, United States

Country:
United States

Website Url:
http://www.recensatherapeutics.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
77 K USD

Technology used in webpage:
SPF Namecheap DNS Namecheap Hosting Namecheap


Similar Organizations

black-belt-therapeutics-logo

Black Belt Therapeutics

Black Belt Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.

cystinosis-research-foundation-logo

Cystinosis Research Foundation

Cystinosis Research Foundation supports bench, clinical, and translational research to find therapeutics for cystinosis.

decedario-logo

Decedario

Decedario is a therapeutic board game for cognitive stimulation.

dnadigest-logo

DNAdigest

DNAdigest is a scientific social enterprise that enables the secure sharing and query of genomics data for research.

genome-explorations-logo

Genome Explorations

Genome Explorations is a research institution that provides global genomic profiling and molecular diagnostics services.

gentec-logo

Gentec

Gentec managed to create things like the first private laboratory to do a genetic edition using CRISPR-Cas9 technology in Mexico.

m-steves-usa-logo

M. STEVES USA

Products that Perform beautyfully to visibly improve skin

not_available_image

PSMA Therapeutics

PSMA Therapeutics is a subsidiary of Noria to advance the platform of prostate-specific membrane antigen (PSMA) targeting radiotherapeutics.

ventrinova-logo

Ventrinova

VentriNova is revolutionizing cardiac regenerative medicine by reversing cardiac damage pharmacologically.

Current Employees Featured

oscar-perez-leal_image

Oscar Perez-Leal
Oscar Perez-Leal Co founder @ Recensa Therapeutics
Co founder

Founder


matthew-handel_image

Matthew Handel

oscar-perez-leal_image

Oscar Perez-Leal

Investors List

phase-1-ventures_image

Phase 1 Ventures

Phase 1 Ventures investment in Pre Seed Round - Recensa Therapeutics

phase-one-ventures_image

Phase One Ventures

Phase One Ventures investment in Pre Seed Round - Recensa Therapeutics

phase-1-ventures_image

Phase 1 Ventures

Phase 1 Ventures investment in Pre Seed Round - Recensa Therapeutics

Official Site Inspections

http://www.recensatherapeutics.com

Unable to get host informations!!!

Loading ...

More informations about "Recensa Therapeutics" on Search Engine